Enhanced vs Conventional Recovery After Breast Surgery
- Conditions
- Patient Satisfaction
- Interventions
- Other: NON-ERAS pathwayOther: ERAS pathway
- Registration Number
- NCT05931796
- Lead Sponsor
- Amal Gouda Elsayed Safan
- Brief Summary
the investigators hypothesize that with the use of enhanced recovery of surgery (ERAS), the postoperative hospital stay after breast surgeries is reduced and also postoperative complications are decreased.
- Detailed Description
Group A NON-ERAS pathway All patients received best of care practice, with standardization of preoperative and postoperative care. Group B ERAS pathway
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 25
-
• Age: 20-60 years.
- Adequate cognitive state (able to understand and collaborate)
- American society of anesthesia (ASA) I, II
-
Patients who are:
- Uncooperative.
- Having allergy to any of the study drugs.
- Known abuse of alcohol or medication.
- Having Local infection at the site of injection or systemic infection.
- Pregnancy.
- With coagulation disorders.
- Any complicated patients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group A NON-ERAS pathway NON-ERAS pathway All patients received best of care practice, with standardization of preoperative and postoperative care Group B ERAS pathway ERAS pathway ERAS consist of approximately 15 elements (or components) that include preoperative, intraoperative, and postoperative interventions .
- Primary Outcome Measures
Name Time Method This study aims to explore the effectiveness and safety of the enhanced recovery after surgery (ERAS) protocol vs. traditional perioperative care programs for modified radical mastectomy. 48 hours visual analogue scale VAS Score (a scale from 0 to 10 where 0 is interpreted as no pain, 1- 4 mild pain, 5-6 moderate pain, 7-10 severe pain) will be recorded 15 min after extubation (as soon as the patient will be alert enough to report pain)' every 1hour for the first 8hours' then every 3hours for the remaining 24 hours.
- Secondary Outcome Measures
Name Time Method Time of first ambulation 48 hours hours
Trial Locations
- Locations (1)
Menoufia university
🇪🇬Cairo, Shibin Elkom, Egypt